Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Henderson Michael Thomas

Over the trailing 90 days, Henderson Michael Thomas (Director at Apogee Therapeutics, Inc.) sold $24.5M of stock across 2 companies, per 17 SEC Form 4 transactions.

Role
Director
Companies
APGE SYRE
Window
Trailing 90 days · 17 transactions · CIK 1779990
Net activity
−$24.5M ($0 bought · $24.5M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
APGEApogee Therapeutics, Inc.11$16.6M−$16.6M
SYRESpyre Therapeutics, Inc.6$8.0M−$8.0M

Transactions (17)

DateSymbolTypeSharesValueDescription
2026-07-10APGESell75.0K$0Gift (bona fide)
2026-07-08APGESell20.0K$2.7MOpen market or private sale
2026-06-22APGESell80.0K$10.6MOpen market or private sale
2026-06-22SYRESell20.0K$2.0MOpen market or private sale
2026-06-10APGESell6.8K$557KOpen market or private sale
2026-06-10APGESell614$53KOpen market or private sale
2026-06-10APGESell2.3K$199KOpen market or private sale
2026-06-10APGESell1.6K$134KOpen market or private sale
2026-06-10APGESell1.1K$91KOpen market or private sale
2026-06-10APGESell7.7K$634KOpen market or private sale
2026-05-27SYREBuy8.0K$0Grant, award or other acquisition
2026-05-13APGESell1.3K$111KOpen market or private sale
2026-05-13APGESell18.7K$1.5MOpen market or private sale
2026-05-08SYRESell19.3K$1.5MOpen market or private sale
2026-05-08SYRESell24.8K$1.9MOpen market or private sale
2026-05-08SYRESell33.5K$2.5MOpen market or private sale
2026-05-08SYRESell2.4K$174KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Henderson's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free